Agoracom Blog

Healthcare IT #Mhealth Market Worth $511.06 Billion by 2027 SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 1:15 PM on Monday, March 9th, 2020

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

Healthcare IT Market Worth $511.06 Billion by 2027

  • Healthcare IT market is expected to grow at a CAGR of 13.8% from 2019 to reach $511.06 billion by 2027.

London, March 06, 2020 – According to a new market research report “Healthcare IT Market by Product (EMR, mHealth, PHM, RIS, PACS, RCM, Healthcare Analytics, Telehealth, SCM, HIE), Component (Software, Service), Delivery Mode (Web, Cloud) and End User (Hospital, Payer, Pharmacy, Ambulatory, Homecare)- Global Forecast to 2027”, published by Meticulous Research®, the healthcare IT market is expected to grow at a CAGR of 13.8% from 2019 to reach $511.06 billion by 2027.

Health Information Technology (Healthcare IT) is a broad term that defines the technology and infrastructure utilized to record, analyze, and share patient health data in healthcare organizations. The aim of Healthcare IT solutions is to offer better care for patients and help accomplish health equity. It also endorses recording of patient data to improve healthcare delivery and allow for analysis of information for both healthcare practitioners and ministry of health/government agencies.

With increasing pressure to curtail healthcare cost and improve healthcare quality, investments in healthcare IT are gaining traction and are largely driven by the need for savings, economies of scale, and improving cash flow. According to a survey performed by Octopus group, more than 100 global institutional investors have planned to increase their investment in healthcare infrastructure, including health IT, by $200 billion over the next five years. By adopting various healthcare IT solutions such as EHR, PACS, and CPOE among others, healthcare organizations have reduced the operational cost and improved savings along with better patient care. For instance, with increasing adoption of Cerner Dynamic Documentation platform, Northern Light Health (U.S.) saved an estimated $1.3 million annually, by increasing provider efficiency, improving satisfaction with their electronic health record, and streamlining the discharge process. Similarly, by adopting Cerner ITWorks, University of Missouri Health Care (U.S.) reduced the organization’s IV obsolescence rate by more than 43% over three months. In addition, the university also adopted Cerner’s revenue cycle management solutions in 2018.

The healthcare IT solutions market study presents historical market data in terms of value (2017, and 2018), estimated current data (2019), and forecasts for 2027 – by product, component, delivery mode, end-user, and geography. The study also evaluates industry competitors and analyzes their market share at the global and regional level.

Based on product type, the healthcare providers solutions segment accounted for the largest share of the healthcare IT market and is slated to grow faster during the forecast period. The large share of this segment is primarily attributed to the factors such as growing focus on patient safety & care, increasing demand for integrated healthcare solutions, rising investments in development of healthcare infrastructure in emerging countries, increasing number of government initiatives & regulatory mandates on implementing eHealth solutions, increasing demand for quality healthcare, and rising awareness about electronic health records (EHRs). In addition, growing geriatric population & related ailments and patient workload on healthcare systems across the globe are also driving adoption of digitization solutions among healthcare providers.

Based on component type, the services segment held the largest share of the overall healthcare IT market. The largest share of this segment is mainly attributed to the increasing need to reduce healthcare costs, shift towards cloud-based services, rising adoption of digital solutions across healthcare organizations, and growing need to reduce administrative overheads of the healthcare industry.

Based on delivery mode, the overall healthcare IT market is segmented into web/cloud based and on-premises. Web & cloud-based solutions accounted for the largest share of the overall healthcare IT solutions market owing to its benefits such as on lower upfront cost, on-demand self-serving deployment model, excessive storage flexibility, and greater security.

Based on the end user, healthcare providers held the largest share of the overall healthcare IT market and is projected to grow at a fastest CAGR during the forecast period. The largest share of this segment is mainly attributed to rising patient volume, growing awareness about electronic health records (EHRs), growing healthcare spending by the countries across globe, and increasing adoption of healthcare IT solutions by healthcare providers.

The report also includes extensive assessment of the product portfolio, geographic analysis, and key strategic developments adopted by leading market participants in the industry over the past 4 years (2016–2019). The healthcare IT solutions market has witnessed number of new product launches, agreements, partnerships & collaborations, expansions, and acquisitions in the recent years. For instance, in October 2019, Cerner collaborated with ResMed (U.S.) to help providers make more informed treatment decisions, control costs, and deliver seamless care across health systems. Similarly, in July 2019, McKesson opened its new distribution center in Puyallup, Washington, U.S. to serve hospitals, health systems, community pharmacies, and national retail pharmacies across the state of Washington.

The key players operating in the global healthcare IT market are McKesson Corporation (U.S.), Optum Health (U.S.), International Business Machine Corporation (IBM) (U.S.), Allscripts Healthcare Solutions, Inc. (U.S.), athenahealth, Inc. (U.S.), Epic Systems Corporation (U.S.), Dell Technologies Inc. (U.S.), GE Healthcare (U.S.), Cerner Corporation (U.S.), Oracle Corporation (U.S.), Cognizant Technology Solutions Corporation (U.S.), Nuance Communications, Inc. (U.S.), eClinicalWorks (U.S.) NextGen Healthcare, Inc. (U.S.), Computer Programs and Systems, Inc. (CPSI) (U.S.), Conifer Health Solutions, LLC. (U.S.), 3M Company (U.S.), Koninklijke Philips N.V. (The Netherlands), and Infor, Inc. (U.S.) among others.

Source: https://www.globenewswire.com/news-release/2020/03/06/1996384/0/en/Healthcare-IT-Market-Worth-511-06-Billion-by-2027-Exclusive-Report-by-Meticulous-Research.html

The new election frontier: #Deepfakes are coming and often target women – SPONSOR: Datametrex AI Limited $DM.ca

Posted by AGORACOM-JC at 12:45 PM on Monday, March 9th, 2020

SPONSOR: Datametrex AI Limited (TSX-V: DM) A revenue generating small cap A.I. company that NATO and Canadian Defence are using to fight fake news & social media threats. The company announced three $1M contacts in Q3-2019. Click here for more info.

The new election frontier: Deepfakes are coming and often target women

By C.J. Moore

  • Deepfake technology has been called a powerful feat in artificial intelligence and machine learning at its best, and unsettling — even sinister — at its worst
  • “Deepfakes could be used to influence elections or incite civil unrest, or as a weapon of psychological warfare,” per the report
  • Also notes that much of deepfake content online “is pornographic, and deepfake pornography disproportionately victimizes women.”

Deepfakes are media — usually videos, audio recordings or photographs — that have been doctored through artificial intelligence (AI) software to fabricate a person’s facial or body movements. They can easily spread by sharing over social media platforms and other websites. 

One well-known example is a video that circulated in August 2019, in which actor Bill Hader does an impersonation of Tom Cruise. The video is edited so Hader’s face morphs into a realistic image of Cruise, giving the impression that it’s the latter talking.

Beyond that, deepfake circulation could be damaging in 2020 and future election cycles. Along with celebrities, government leaders are the most common subjects of deepfakes, according to a February Science and Tech Spotlight from the U.S. Government Accountability Office (GAO).

“Deepfakes could be used to influence elections or incite civil unrest, or as a weapon of psychological warfare,” per the report. It also notes that much of deepfake content online “is pornographic, and deepfake pornography disproportionately victimizes women.”

In 2018, Reddit shut down r/deepfakes, a forum that distributed videos of celebrities whose faces had been superimposed on actors in real pornography. The computer-generated fake pornography was banned because it was “involuntary,” or created without consent. 

Much of the same technology used to make those videos could be used to exploit women running for office, according to a GAO official.

“We can’t speak to intent, but the result is definitely that the majority of these do target women,” said Karen Howard, a director on GAO’s Science, Technology Assessment and Analytics (STAA) team.

Read More: https://www.michiganadvance.com/2020/03/09/the-new-election-frontier-deepfakes-are-coming-and-often-target-women/

For #Edtech startups, it’s raining money – SPONSOR: BetterU Education Corp. $BTRU.ca $ARCL $CPLA $BPI $FC.ca

Posted by AGORACOM-JC at 11:52 AM on Monday, March 9th, 2020
SPONSOR:  BetterU Education Corp. aims to provide access to quality education from around the world. The company plans to bridge the prevailing gap in the education and job industry and enhance the lives of its prospective learners by developing an integrated ecosystem. Click here for more information.

For edtech startups, it’s raining money

Tracxn data reveals that Bengaluru-based companies attracted the lion’s share (about $944 million) of investments in the edtech space in the last one year, the highest across cities in India.

By Debojyoti Ghosh

  • Education-technology or edtech companies have mastered the art of wooing investors.
  • The numbers are telling.
  • In less than three months into the new year, edtech ventures have garnered a whopping $686.32 million in 21 funding rounds, a steep surge from $450 million in 87 rounds in the entire 2019, according to data from analytics firm Tracxn.

The data reveals that Bengaluru-based companies attracted the lion’s share (approximately $944 million) of investments in the edtech space in the last one year, the highest across cities in India.

According to data Fortune India has collected, Mumbai-based startups were next in line: raising $109.3 million during the same period. Startups based in Gurugram raised a total of $33.19 million, coming in third. The data includes funding rounds between January 1, 2019, and February 29, 2020.

This year alone, Bengaluru-headquartered Byju’s raised about $500 million, says Tracxn, at an estimated valuation of close to $8 billion. Last month, smaller crosstown rival Unacademy raised $110 million in a funding round led by Facebook and General Atlantic. At the same time, Bengaluru-based interactive online tutoring platform Vedantu raised $24 million, led by global venture capital firm GGV Capital.

Can this buoyancy be sustained?

In the last few years, edtech companies have ramped up their interactive online tutoring content, targeting school students and candidates preparing for competitive examinations and government jobs across metros and tier 2 cities.

RedSeer Consulting, a research and advisory firm focussed on the consumer internet market, noted in its last year’s report that the first wave of edtech companies saw players focussing on high-quality content and live streaming, most often catering to metro/tier 1 users and in English as the major medium of instruction.

“However, our research on learners across market segments (K12, test prep, professional learning) clearly shows a strong need for vernacular education—something which most offline and online platforms fail to provide adequately as of now. Thus, there is a strong underlying need for digital education in vernacular languages,” the RedSeer report said.

Players such as Gurugram-based Doubtnut target students in smaller cities providing learning content in vernacular languages. In January, Doubtnut raised $15 million in a Series A funding round, led by Chinese investor Tencent. Existing investors Omidyar Network India, AET, Japan, Cure.fit co-founder Ankit Nagori, and Sequoia Capital India also participated in the funding round.

Online learning platform Adda247—which provides live video classes, on-demand video courses, mock tests and test prep focussing on examinations for government jobs—also caters to the vernacular segments, particularly the Hindi-speaking belt.

“Across the K12 and professional learning space, players with video lectures have been tailoring to blend English and Hindi in their delivery to drive customer engagement,” RedSeer said.

Other funding announcements this year for edtech startups include Testbook, which in January raised about $8.3 million in a Series B round led by venture capital fund Iron Pillar. The Mumbai-based online preparatory platform provides learning content and test prep for competitive government examinations. Noida-based edtech startup Classplus raised $2.5 million in a pre-Series A funding round from Blume Ventures, Sequoia Capital and others.

With funding available across the various stages of growth, only time will tell if edtech companies can maintain the momentum for the rest of the year.

Source: https://www.fortuneindia.com/bengaluru-buzz/for-edtech-startups-its-raining-money/104233

Hollister Biosciences $HOLL.ca Signs Definitive Agreement to Acquire Venom Extracts With $16.4 Million in Revenue and $2.48 Million EBITDA $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 4:48 PM on Friday, March 6th, 2020
  • This highly accretive acquisition will strengthen Hollister’s brand portfolio and broaden its distribution across multiple states
  • For the year ended December 31, 2019, Venom Extracts reports having generated CDN$ 16.4 million in revenue and CDN$ 2.48 million in EBIDTA from its product line of Cannabis Concentrates, P.H.O Concentrates and Cartridges.

VANCOUVER, March 6, 2020 – Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT: HOB, OTC: HSTRF) (the “Company” or “Hollister“) – a diversified cannabis branding company with products in 220 dispensaries throughout California, is pleased to announce the Company has entered into a definitive agreement  (the “Agreement“) on March 6th, 2020 to acquire Venom Extracts ( “Venom“), one of Arizona’s premier extract brands and one of the state’s largest producers of award-winning medical cannabis distillate and related products.

On February 25, 2020, the Company first announced a Letter of Intent to acquire Venom, including the following financial figures and terms.

HIGHLY ACCRETIVE $20,000,000 ACQUISITION

For the year ended December 31, 2019, Venom Extracts reports having generated CDN$ 16.4 million in revenue and CDN$ 2.48 million in EBIDTA from its product line of Cannabis Concentrates, P.H.O Concentrates and Cartridges. 2019 Revenue and EBITDA for Venom Extracts are as reported by Management. Though Hollister believes the figures to be highly reliable, their audit will be part of the ongoing due diligence before closing.   

The all stock purchase price is anticipated to be CDN$ 20,000,000, with 70% to be paid upfront and 30% to be paid upon milestone achievements related to revenue targets for Venom. The acquisition is expected to close by March 31, 2020 subject to normal course due diligence.

KEY TERMS OF THE AGREEMENT:

  • The Company will acquire Venom Extracts for CDN$20,000,000 with such payment to be issued in Hollister common stock (the “Payment Shares“)
  • The stock price will be determined based on the greater of:
    • The 14-day VWAP (Volume Weighted Average Price) capped at $0.25 subsequent to announcing the transaction and $0.20
  • Once the share price is established, 70% of the Payment Shares will be issued upon closing of the transaction, subject to hold periods
  • The remaining 30% of the Payment Shares will be issued when and if the following milestones have been met on or prior to December 31st, 2021:
    • 20% (of the total number of Payment Shares) will be issued when revenue of Venom Extracts reaches CDN$ 30,000,000 (calculated in accordance with IFRS from January 1, 2020).
    • 10% (of the total number of Payment Shares) will be issued when revenue of Venom Extracts reaches CDN$ 40,000,000(calculated in accordance with IFRS from January 1, 2020).

“We are very pleased to have entered into a definitive agreement to complete this transformational acquisition”, shared Carl Saling, Founder and CEO of Hollister Biosciences, Inc.  “Financially, we are bolting on substantial revenue and EBITDA, while strategically, this allows for the opportunity to bring Venom into the California marketplace and help scale Hollister’s existing operation. Likewise, it allows for the opportunity to introduce Hollister’s products into the Arizona and Nevada marketplaces to start with.” 

“This is an exciting acquisition and we are happy to be taking this critical step toward closing”, shared Jacob Cohen, Founder of Venom Extracts.  “This transaction represents the next step in ensuring the future growth of both Hollister and Venom.  We are looking forward to increasing the geographic scope of our operation by expanding into the California marketplace through Hollister’s existing platform, as well as, exploring expansion of our existing product scope collectively.”

In association with the acquisition, Hollister will not be assuming any long-term debt, a new control position will be created and there is no change in Management, or the Board of Directors of Hollister being contemplated at this time.

Finder’s fees will be payable in accordance with the policies of the Canadian Securities Exchange.

This press release is available on the Company’s CEO Verified Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.

About Hollister Biosciences Inc.

Hollister Biosciences Inc. is a diversified cannabis company with multiple, high-quality products now carried in 220 of Indus Holdings (CSE: INDS), Hollister’s exclusive distribution partner’s 600 dispensaries. This level of penetration is expected to grow as the Company accelerates its seed to shelf, high margin business and product development model.

Capitalizing on this success, Hollister’s vision is to become the sought-after premium brand portfolio of innovative, high quality cannabis across multiple states and hemp products nationwide.

Our wholly owned California subsidiary, Hollister Cannabis Co, is the 1st state and locally licensed Cannabis Company in the City of Hollister, California, the birthplace of the “American Biker” from which we embrace the outlaw roots of Hollister to drive our Company fearlessly down the road of success.

Products from Hollister Cannabis Co. include HashBone, the brand’s premier artisanal hash-infused pre-roll ranked as California’s #1 hash infused pre-roll, along with solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures.

Website:  www.hollistercannabisco.com 

About Venom Extracts

Venom Extracts is one of Arizona’s premier extract brands and one of the state’s largest producers of award-winning medical cannabis distillate and related products.  With an experienced management team and unparalleled reputation for quality, Venom Extracts prides itself as a differentiated extraction company by producing legal Marijuana products at a price point that allows retailers to generate higher profits.  Focused on proprietary efficiencies, the Company is able to produce more product per square foot than its competition, maintaining lower costs and risks than a typical extraction company. The company’s expansion strategy is centered on entering new markets/states that are approved for medical cannabis use and/or approved or have a reasonable expectation to be approved for recreational use in the near future.  

Website:  www.venomextracts.com

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile onwww.sedar.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/hollister-biosciences-signs-definitive-agreement-to-acquire-venom-extracts-with-16-4-million-in-revenue-and-2-48-million-ebitda-301019220.html

SOURCE Hollister Biosciences Inc.

#Palladium, #rhodium demand to remain, despite #virus outbreak SPONSOR: New Age Metals $NAM.ca $WG.ca $XTM.ca $WM.ca $PDL.ca $GLEN

Posted by AGORACOM-JC at 5:40 PM on Thursday, March 5th, 2020

SPONSOR: New Age Metals Inc. The company owns one of North America’s largest primary platinum group metals deposit in Sudbury, Canada. Updated NI 43-101 Mineral Resource Estimate 2,867,000 PdEq Measured and Indicated Ounces, with an additional 1,059,000 PdEq Ounces Inferred. Learn More.

Palladium, rhodium demand to remain, despite virus outbreak: analyst

  • Though the coronavirus outbreak may affect near-term automobile demand, long-term demand for palladium and rhodium will remain unchanged

By: Nick Jonson

Washington — Though the coronavirus outbreak may affect near-term automobile demand, long-term demand for palladium and rhodium will remain unchanged unless automakers substitute for other metals, managing director Frederic Panizzutti of MKS Dubai said.

“If I was a carmaker, I would definitely stock palladium while the price is lower, and I believe this is going to keep palladium strong, even if the demand goes down in China, the UK, or the demand for parts decreases,” Panizzutti said in an interview this week.

Rhodium and palladium, along with platinum, are used in automobile catalytic converters to control emissions of certain greenhouse gases and pollutants.

“It’s a bargain for car manufacturers to be able to acquire palladium if it goes lower; it’s been a one-way street for months now,” Panizzutti said, referring to the recent rallies in palladium and rhodium.

NYMEX palladium has risen nearly 25% since the start of the year to reach an intraday high of $2,789.80/oz on February 27. NYMEX palladium for June delivery closed at $2,469.40/oz on Thursday.

Rhodium, which is not traded on major exchanges, has risen nearly 114% since the start of the year. The Platts New York Dealer rhodium price was assessed at $12,700-$13,000/oz on February 27.

Analysts have attributed the sharp price increase to automakers trying to secure enough metal for catalytic converters that meet new emissions standards in China, India and Europe, as well as the US and UK.

Further spread of the coronavirus outbreak globally could reduce automobile demand, along with the projected 1 million oz supply deficit in palladium, Panizzutti said.

The China Passenger Car Association on Wednesday said new car sales in China had plummeted 80% in February from a year ago, the biggest monthly decline on record, though it declined to provide a figure.

Analysts attributed the declining sales to government restrictions to limit the spread of the coronavirus in China, where it began in Hubei Province. Hubei is a major auto manufacturing hub in China.

But even if the coronavirus outbreak becomes a global pandemic, governments and businesses will have to adapt as they do nearly every year with widespread influenza outbreaks, Panizzutti said.

Automobile production, and by extension palladium and rhodium demand, would continue, though possibly at a lower rate, he added.

PLATINUM SUBSTITUTION

“I believe the palladium price now is far over the threshold that automakers are willing to accept,” Panizzutti said.

But substituting platinum for palladium in catalytic converters takes time due to design and testing procedures, he noted.

“In my opinion, it should happen, whether it takes several months or longer because the palladium situation is unsustainable. And I see no reason why the situation should change if nothing changes in the supply/demand balance,” Panizzutti said.

“And the only way to change the supply/demand balance is to switch partially or totally from palladium to platinum. If there is no switch, the situation will be the same and will remain a struggle for manufacturers to get hold of material,” he said.

Source: https://www.spglobal.com/platts/en/market-insights/latest-news/metals/030520-palladium-rhodium-demand-to-remain-despite-virus-outbreak-analyst

Trusting video in a fake news world – SPONSOR: Datametrex AI Limited $DM.ca

Posted by AGORACOM-JC at 5:10 PM on Thursday, March 5th, 2020

SPONSOR: Datametrex AI Limited (TSX-V: DM) A revenue generating small cap A.I. company that NATO and Canadian Defence are using to fight fake news & social media threats. The company announced three $1M contacts in Q3-2019. Click here for more info.

Trusting video in a fake news world

  • fake news is a tricky problem to solve, is probably not news to anyone at this point
  • However, the problem stands to get a lot trickier once the fakesters open their eyes to the potential of a mostly untapped weapon: trust in videos

By: Mansoor Ahmed-Rengers

That fake news is a tricky problem to solve, is probably not news to anyone at this point. However, the problem stands to get a lot trickier once the fakesters open their eyes to the potential of a mostly untapped weapon: trust in videos.

Fake news so far has relied on social media bubbles and textual misinformation with the odd photoshopped picture thrown in here and there. This has meant that, by and large, curious individuals have been able to uncover fakes with some investigation.

This could soon change. You see, “pics or it didn’t happen” isn’t just a meme, it is the mental model by which people judge the veracity of a piece of information on the Internet. What happens when the fakesters are able to create forgeries that even a keen eye cannot distinguish? How do we distinguish truth from fact?

We are far closer to this future than many realise. In 2017, researchers created a tool that produced realistic looking video clips of Barack Obama saying things he has never been recorded saying. Since then, a barrage of similar tools have become available; an equally worrying, if slightly tangential, trend is the rise of fake pornographic video that superimpose images of celebrities on to adult videos.

These tools represent the latest weapons in the arsenal of fake news creators – ones far easier to use for the layman than those before. While the videos produced by these tools may not presently stand up to scrutiny by forensics experts, they are already good enough to fool a casual viewer and are only getting better. The end result is that creating a good-enough fake video is now a trivial matter.

There are, of course, more traditional ways of creating fake videos as well. The White House was caught using the oldest trick in the book while trying to justify the barring of a reporter from the briefing room: they sped up the video to make it look like the reporter was physically rough with a staff member.

Other traditional ways are misleadingly editing videos to leave out critical context (as in the Planned Parenthood controversy), or splicing video clips to map wrong answers to questions, etc. I expect that we will see an increase in these traditional fake videos before a further transition to the complete fabrications discussed above. Both represent a grave danger to the pursuit of truth.

Major platforms are acutely aware of the issues. Twitter has recently introduced a fact checking feature to label maliciously edited videos in its timeline. YouTube has put disclaimers about the nature of news organizations below their videos (for example, whether it is a government sponsored news organization or not). Facebook has certified fact checkers who may label viral stories as misleading.

However, these approaches rely on manual verification and by the time a story catches the attention of a fact checker, it has already been seen by millions. YouTube’s approach is particularly lacking since it doesn’t say anything about an individual video at all, only about the source of funding of a very small set of channels.

Now, forensically detecting forgeries in videos is a deeply researched field with work dating back decades. There are many artefacts that are left behind when someone edits a video: the compression looks weird, the shadows may jump in odd patterns, the shapes of objects might get distorted.

Source: https://www.opendemocracy.net/en/digitaliberties/trusting-video-fake-news-world/

First Look at the Nine CBD Consumer Archetypes in Europe SPONSOR: Mota Ventures $MOTA.ca $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 3:47 PM on Thursday, March 5th, 2020

SPONSOR: Mota is seeking to become a vertically integrated global CBD brand. Mota is looking to establish sales channels and a distribution network internationally through the acquisition of the Sativida and First Class CBD brands. Low cost production, coupled with international, direct to customer sales channels will provide the foundation for the success of Mota. Click Here for More Info

Mota large
  • New Frontier Data’s second consumer report in its EU CBD series provides a comprehensive overview of the European CBD consumer experience

New Frontier Data, the global authority in data, analytics and business intelligence on the cannabis industry, publishes the second volume of its EU CBD Consumer Report Series: Segmentation & Archetypes, in partnership with Deep Nature Project and Mile High Labs. Drawing from the groundbreaking surveying of over 3,000 European CBD consumers across 17 European nations, this study results in the most comprehensive consumer archetype report for European CBD consumers to date.

“Europe’s booming consumer interest in CBD and CBD-infused products across the Food & Beverage and Health & Beauty sectors continues to create material B2B and B2C market opportunities. Data-driven insights of both EU and North American CBD consumerism, drawing from not only comparative analysis but also known geo-centric market dynamics and drivers, helps us educate and guide brands on how to address CBD consumer priorities while managing known or expected challenges in this new CBD space,” said New Frontier Data Founder & CEO Giadha Aguirre de Carcer. “This report fills a major gap in business intelligence in the CBD industry not only in Europe, but worldwide, providing new and existing cannabis or hemp industry stakeholders with a uniquely valuable and timely resource.”

Key findings from the report include:

  • 4 of the 5 consumer archetypes have purchased CBD; the Ambivalent & Experimental Consumers instead source CBD from family and friends
  • The largest consumer archetype, the Integrative & Consistent Consumers, are frequent users and staunch believers in CBD’s medical efficacy
  • 26% of Europeans aged 18-34 have tried CBD, compared to 16% of the general population
  • 73% of self-reported consumers claimed CBD has positively affected their quality of life
  • A third (34%) of non-consumers are somewhat or very curious about trying CBD
  • 49% of CBD purchasers who did not themselves consume indicated buying it for a family member
  • Male consumers report spending more on CBD products than female consumers, with more than a third of men (35%) reporting spending €100 or more per month
  • 72% of consumers and 17% of non-consumers considered themselves likely to purchase CBD in the next 6 months
  • Consumers who use CBD primarily for medical reasons were the most frequent CBD consumers, with nearly half (45%) consuming it at least daily

The EU CBD Consumer Report Series: Segmentation & Archetypes is available for FREE Download at: https://newfrontierdata.com/product/the-eu-cbd-consumer-report-2020-segmentation-and-archetypes/

About New Frontier Data:

New Frontier Data is an independent, technology-driven analytics company specializing in the global cannabis industry. It offers vetted data, actionable business intelligence and risk management solutions for investors, operators, researchers and policy makers. New Frontier Data’s reports and data have been cited in over 80 countries around the world to inform industry leaders. Founded in 2014, New Frontier Data is headquartered in Washington, D.C., with additional offices in Denver, CO and London, UK.

New Frontier Data does not take a position on the merits of cannabis legalization. Rather, its mission and mandate are to inform cannabis-related policy and business decisions through rigorous, issue-neutral and comprehensive analysis of the legal cannabis industry worldwide. For more information about New Frontier Data, please visit: https://www.NewFrontierData.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200303005341/en/

MINING.COM Launches EV Battery Metals Index SPONSOR: Lomiko Metals $LMR.ca $CJC.ca $SRG.ca $NGC.ca $LLG.ca $GPH.ca $NOU.ca

Posted by AGORACOM at 2:34 PM on Thursday, March 5th, 2020

SPONSOR: Lomiko Metals is focused on the exploration and development of minerals for the new green economy such as lithium and graphite. Lomiko owns 80% of the high-grade La Loutre graphite Property, Lac Des Iles Graphite Property and the 100% owned Quatre Milles Graphite Property. Lomiko is uniquely poised to supply the growing EV battery market. Click Here For More Information

The value of metals used in batteries for the nascent electric vehicle industry measured for the first time

It is worth remembering that the first all-electric vehicle to use a lithium-ion battery –  the Tesla roadster – only rolled off assembly lines in 2008. 

And the blue-sky scenarios and exuberant forecasts for electric vehicle demand and mining only really started to make headlines three or four years ago. 

And those headlines came just at the right time for an industry at the bottom of a brutal business cycle and in desperate need of a feelgood news story. 

Not that the feeling lasted all that long. 

All of mining is mercifully free of the ravages of price stability, but even tulip bulbs took longer from boom to bust than EV metals. 

But how does falling prices for lithium, cobalt, graphite and nickel square with demand forecasts that all start in the bottom left corner and end in the top right?

Pedal to the metal

To get a better grip on the nascent sector, MINING.COM combined two sets of data: 

  • First, prices paid for the mined minerals at the point of entry into the global battery supply chain.

    London-based Benchmark Mineral Intelligence, a global battery supply chain, megafactory tracker and market forecaster, provides MINING.COM with monthly sales-weighted price data.
  • Second, the sales weighted volume of the raw materials in electric and hybrid passenger car batteries sold around the world.

Toronto-based Adamas Intelligence, which tracks demand for EV batteries by chemistry, cell supplier and capacity in over 90 countries provides the data for the raw materials deployed.

Benchmark has been tracking megafactory construction since Tesla broke ground on the first of its kind in June 2014. Adamas completes the chain, recording all that battery power hitting the road. 

That makes the MINING.COM EV Metals index more than a mine to market measure. More like mine to, er, garage.

The inaugural MINING.COM EV Metals Index shows an industry in better shape than what tanking prices and dismal headlines would suggest. 

In fact, the nickel sub-index is at a record high and cobalt bulls would be happy to know that the metal feeding the battery supply chain had its biggest month in nine.

Click for full size chart

Where the rubber, only the rubber, meets the road

If you take Tesla’s stock price as a guide (and I know a bunch of short sellers who would rather pluck their own eyes out than do that) the essential ingredients of muskmobiles should not be languishing at multi-year lows.

Last year, Elon Musk said getting more Teslas on the road is dependent on scaling battery production and to scale at the fastest rate possible it may be necessary to get into mining, “at least a little bit.” 

The last auto exec to venture into mining was Henry Ford

The last auto exec to venture into mining was Henry Ford. When the equivalent of an over the air update was a hand crank and cars could only be had in black and not four (wow!) other colours like the Model S. 

Crucially, at the time the cost of raw materials had a much bigger bearing on the final price of a car. In EV production the battery can be up to 50% of the cost of production and raw materials the bulk of that.  

A seminal study on EVs by UBS showed the only commodity your average EV (Chevy Bolt) and ICE car (VW Golf) have in equal amounts, is rubber. (Ford, btw, also owned a rubber plantation in Brazil.)    

That’s how much of a change the switch to electric vehicles represents in the auto industry’s raw material supply chain. 

Rocks down to electric avenue

Yet here we are.

Newbie investors are taking a crash course in surviving a sector that can turn on a dime.

Juniors are being scared off. Bodies are piling up among developers. Producers’ grand ambitions have been thwarted. Contracts have been reneged on. 

It’s difficult to see the disconnect on fundamentals lasting that much longer – governments’ green demands and emissions strictures are only intensifying and carmakers’ programs are only becoming more lavish. 

Volkswagen promises 80 all electric models across its brands by 2025. Three hundred by the end of the decade. 

While miners are encountering the pitfalls of vertical integration, the global auto industry is getting a crash course in mining lead times

A year ago already, Wolfsburg said it was allocating $48 billion for EV development.

And then you also read that Audi (a VW brand) and Mercedes Benz had to suspend production due to a battery shortage (long before coronavirus). 

While miners are encountering the pitfalls of vertical integration, the global auto industry is getting a crash course in mining lead times and how tiny markets (annual global cobalt mining revenue is less than what VW collects in a week) can impact giant industries.  

In total, the world’s automakers have committed $300 billion for making rides you have to plug into a wall, Benchmark estimates. Or to use the car industry term, $300 billion for ushering in a new epoch of sustainable mobility.

Neither is there a shortage of government support for the transition. Unlike AOC’s, the EU’s $1 trillion green new deal may actually get off the starting grid, and Beijing has ordered 25% of cars sold must be EVs within five short years. 

Lithium nirvana 

MINING.COM compiled the data for lithium prices from Benchmark and lithium deployment from Adamas going back eleven years. 

It just shows again that the EV raw materials industry is in its infancy.

Click for full size chart

For calendar year 2009, the electric and hybrid cars sold around the world contained a paltry 31 tonnes of lithium in their batteries worth a combined $182K (that’s a K not an m).  

Eleven years later, the industry had grown 3,330-fold for a value of $609m. Ok, that’s just having fun with the base effect, but measured just over the last five years the annualized value of lithium in EVs are up more than 1,000%

And that’s despite a contraction in 2019. Lithium price tripled between April 2015 and peaked three years later, only to tumble by 60% in value since then. 

Graphite was the first to peak in early 2012, but has since halved. The value of graphite deployed in EVs is up 370% in three years. And as a percentage of the index, graphite has in fact steadily increased its share.

The bigger picture is one of an industry that is still expanding. And at a breakneck pace.

Cobalts from the blue 

Given its tricky fundamentals, cobalt is always going to be a conundrum for investors and a headache for carmakers. 

It’s the priciest component and the most volatile. At its peak, Co made up as much as 55% of the cost of raw materials for batteries. Despite a plummeting price and ongoing thrifting, it still makes up a third of the input cost. 

 Given that almost two-thirds primary supply is from the Congo and more than 80% of processing capacity is located in China, cobalt’s spike to just shy of $110,000 a tonne in April 2018 was understandable. 

That 15 months later it was below $26,000, less so. 

At the stroke of a pen, Beijing can change market dynamics completely. Its subsidy cuts last year crumpled a market growing at more than 60% the year before. 

In February, Tesla – which in good months sells more battery capacity than its three nearest rivals combined – surprised cobalt and nickel bulls by opting for batteries at its Shanghai plant that forego both.

At the time of writing, the impact of the four Cs – cobalt-Congo-China-coronavirus – is far from clear. But as the graph shows, cobalt bulls had something to celebrate in the second half of last year.

Better than the devil’s copper you know   

Batteries account for only 6% of global nickel demand today, meaning investors buying into the sulphates story also take a hit when Jakarta convulses the nickel pig iron trade. 

MINING.COM’s inaugural index shows nickel setting a new monthly record at the end of last year, despite the sharp retreat in prices since September. 

The increasing use of nickel rich cathodes also means its contribution to the value mix has almost doubled in a year to more than 18%. 

As nickel-rich chemistries increasingly dominate the EV market, the average sales weighted value of nickel on a per vehicle basis is rising sharply – to over $100 in December from $67 a year earlier or from less than a quarter of the cost of the cathode’s cobalt to half that.   

The combined value of lithium, graphite, cobalt and nickel based on sales weighted average deployed per vehicle was under $600. 

When prices were peaking in early 2018 those raw materials cost more than $1,500 per vehicle. Not the battery, just the raw materials.

In the longer run, nickel for batteries could be as big a market as for stainless steel, which would be equivalent to gold’s use in electronics, becoming a $100 billion industry, from an afterthought today. 

Kalahari thirst 

Adamas data shows that NCM (nickel-cobalt-manganese) and NCA (nickel-cobalt-aluminum) cathodes had a 94% market share in December, based on  total battery capacity deployed globally. 

MINING.COM is not tracking manganese as EV dynamics have almost no bearing on its price. 

High-purity manganese sulphate usually sells at a healthy premium, but as a component of NCM batteries, no auto exec is losing sleep over manganese costs or supply.

Likewise aluminum, despite significantly higher use in EVs.

 That said, in an all-EV world battery-grade manganese demand could make the Kalahari desert, home to the oldest population of humans on earth and 70% of global reserves,  a point of contention not unlike cobalt and the Congo (minus the child labour and ongoing violent conflict). 

 We lose money on every sale, but make it up on volume 

 Call them giga or mega, your average battery manufacturing plant is huge.

 There are more than 100 megafactories in the pipeline around the world – 14 of them in Europe. 

MINING.COM’s prediction is that 2019 wasn’t only the first annual fall in the index, but also the last

 Last year battery power deployed rose 30% globally. In Europe, gigawatt hours hitting the road grew 89%. 

To feed those factories to power those cars requires the extraction of lithium, graphite, cobalt and nickel to increase by magnitudes.  

The MINING.COM EV Metals Index shows that the gap between future supply and future demand has become a chasm. 

MINING.COM’s prediction is that 2019 wasn’t only the first annual fall in the index, but also the last.

SOURCE: https://www.mining.com/mining-com-launches-ev-battery-metals-index/

Novo Swaps Stock with Canadian Gold Explorer New Found Gold SPONSOR: Labrador Gold $LAB.ca $RIO.ca $WHM.ca $SIC.ca $NXS.ca

Posted by AGORACOM at 12:23 PM on Thursday, March 5th, 2020

SPONSOR: Labrador Gold – Two successful gold explorers lead the way in the Labrador gold rush targeting the under-explored gold potential of the province. Exploration has already outlined district scale gold on two projects, including a 40km strike length of the Florence Lake greenstone belt, one of two greenstone belts covered by the Hopedale Project. Recently acquired 14km of the potential extension of the new discovery by New Found Gold’s Queensway project to the south. Click Here for More Info

This image has an empty alt attribute; its file name is LAB-square-logo-2.png
Conglomerate gold player, Novo Resources, has swapped scrip to take a piece of New Found Gold Corp, giving it exposure to the Newfoundland gold prospect
  • Dr. Quinton Hennigh said: “We at Novo think the Queensway Project represents a very promising new high-grade gold discovery. It appears the Queensway Project encompasses an area highly prospective for high-grade, epizonal orogenic gold mineralization

TSX-listed, Pilbara-focused gold player, Novo Resources, has acquired 15.97 per cent of New Found Gold Corp via a scrip-for-scrip deal that gives Novo access to New Found’s stellar gold prospect on the east coast of Canada. Novo says that the New Found tenement package is the largest in the Province of Newfoundland and Labrador.

A recent drill intercept at New Found’s Queensway project located near the town of Gander in central Newfoundland returned 19m at 3 ounces to the tonne from 98m, including 6m at a staggering 9oz/tonne gold. Novo says the intercept has an estimated true width of around 70 per cent of the 19m hit, making it an extraordinary hole.

According to New Found’s management, this drill hole is adjacent to historical surface workings and only 2km from an historical gold resource.

Novo said that Eric Sprott, a director of Novo, was sitting on 16.79% of the issued and outstanding shares of New Found immediately prior to the acquisition. New Found is considered a non-arm’s length party to Novo pursuant to TSX Venture Exchange policies and the deal is subject to the approval of the Exchange.

Under the terms of the acquisition, Novo also has the right to appoint a director to the board of directors of New Found at any time for a period of three years from the acquisition date provided that the company holds no less than 10% of New Found’s issued and outstanding shares. Novo has also agreed to certain voting restrictions for a period of three years.

President and Chairman of Novo Resources, Dr. Quinton Hennigh said: “We at Novo think the Queensway Project represents a very promising new high-grade gold discovery. It appears the Queensway Project encompasses an area highly prospective for high-grade, epizonal orogenic gold mineralization. We are very pleased to have the opportunity to be part of this exciting discovery and, upon completion of the Acquisition, look forward to supporting New Found as they advance work around hole NFGC-19-01 and the many other high-grade showings across the Queensway Project.”

Whilst Novo has been and remains focused on delivering its Pilbara-based conglomerate gold project, the acquisition of an interest in New Found is the second of its kind for Novo. The TSX-listed company announced back in January this year that it had subscribed for shares in ASX-listed Kalamazoo Resources in a financing arrangement that will, upon closing, give Novo 8.17 per cent of Kalamazoo’s issued and outstanding shares.

Novo said that Kalamazoo has a string of prospects in the Bendigo-Castlemaine region of Victoria in Australia and its prospects have strong similarities to the 1Moz Fosterville gold deposit being mined underground by TSX-listed Kirkland Lake Gold at an average grade of 31g/t gold.

Interestingly, Eric Sprott, Novo director, is also a shareholder in Kalamazoo.

With a market cap approaching the equivalent of half a billion Australian dollars, Novo can make scrip-based acquisitions such as New Found and Kalamazoo with ease.

The impact on its share capital is minimal but the upside is potentially serious if either of its current or future based bets come good – and with 19m going 3 ounces to the tonne, New Found just might fit into that category.

SOURCE: https://thewest.com.au/business/public-companies/novo-swaps-stock-with-canadian-gold-explorer-c-728949

DEA Proposes New #Mhealth Rule for Substance Abuse Treatment SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 12:14 PM on Thursday, March 5th, 2020

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

DEA Proposes New Mhealth Rule for Substance Abuse Treatment

A proposed rule change would allow providers to use mHealth tools more freely in substance abuse treatment programs, but it isn’t the rule that telehealth advocates have been anticipating.

By Eric Wicklund

March 04, 2020 – Federal officials have proposed easing restrictions on the use of mHealth in substance abuse programs – but the changes aren’t what everyone has been expecting.

Under a notice of proposed rulemaking published last month in the Federal Register, the US Drug Enforcement Agency would allow registered narcotic treatment programs (NTPs) using “mobile components” to consider those connected health elements as a coincident activity.

“The NTP registrants that operate or wish to operate mobile components (in the state that the registrant is registered in) to dispense narcotic drugs in schedules II-V at a remote location for the purpose of maintenance or detoxification treatment would not be required to obtain a separate registration for a mobile component,” a summary of the rule states.

“This proposed rule would waive the requirement of a separate registration at each principal place of business or professional practice where controlled substances are dispensed for those NTPs with mobile components that fully comply with the requirements of the proposed rule, once finalized,” the summary continues. “These revisions to the regulations are intended to make maintenance or detoxification treatments more widely available, while ensuring that safeguards are in place to reduce the likelihood of diversion.”

The notice is different from what telehealth and mHealth providers have been waiting for: a rule that would ease federal restrictions on the prescription of scheduled drugs via telemedicine, and one that federal officials had been expected to unveil. It even prompted Virginia Sen. Mark Warner to issue a press release congratulating the DEA on making that move.

“The opioid and addiction epidemic has had a devastating impact on communities in Virginia and across the country,” Warner, who had sent a letter to the DEA in January, said in a press release that has since been deleted. “We need to use every tool at our disposal to ensure that individuals struggling with addiction can access the treatment they need, and telehealth is an important part of that. I am pleased the DEA has finally issued proposed rulemaking that will improve telehealth access for these patients and I hope they will work quickly to finalize this rulemaking once stakeholders have had an opportunity to weigh in.”

With the Special Registration for Telemedicine Act of 2018, which was part of the SUPPORT for Patients and Communities Act signed into law by President Donald Trump in late 2018, the DEA had until October 24, 2019 to set the ground rules for providers with a special registration to prescribe controlled substances.

That deadline passed without action. In November, the Justice Department announced plans to issue a proposed rule to create that registration process. But nothing has happened since then, and the DEA and other federal agencies have refused to give any updates.

Last month’s ruling leaves healthcare providers looking for more leeway in treating substance abuse issues both pleased and disappointed. It’s a step in the right direction for programs using digital health tools, but not the leap forward that so many have been anticipating.

Source: https://mhealthintelligence.com/news/dea-proposes-new-mhealth-rule-for-substance-abuse-treatment